Fish oil-containing lipid emulsions in patients with sepsis.
Lipid emulsions based on soybean oil have been an integral part of parenteral nutrition supplying n-6 fatty acids, with possible negative effects in critically ill patients. Newer lipid emulsions supply less n-6 fatty acids. In addition, fish oil-based lipids may be included in the lipid component of parenteral nutrition. While clinical benefits of lipid emulsions with a reduced fraction in n-6 lipids and the addition of fish oil have been described in postoperative patients, data are less clear in critically ill or septic patients. Recent data suggest that beneficial effects may be achieved when used early but clearly more data are needed to come to a definitive conclusion. The present commentary will highlight current data in critically ill and septic patients and the use of fish oil as a part of parenteral nutrition.
Mayer
Konstantin
K
University of Giessen Lung Center, Medical Clinic II, Justus-Liebig-University Giessen, Klinikstrasse 36, Giessen, Germany. Konstantin.Mayer@innere.med.uni-giessen.de
Seeger
Werner
W
D016638:Critical Illness; D005217:Fat Emulsions, Intravenous; D005395:Fish Oils / Q000008:administration & dosage*; D006801:Humans; D010288:Parenteral Nutrition / Q000379:methods*; D018805:Sepsis / Q000178:diet therapy*
D005217:Fat Emulsions, Intravenous; D005395:Fish Oils